Search Results - "Baeuerle, P.A."

Refine Results
  1. 1

    H2O2 and antioxidants have opposite effects on activation of NF‐kappa B and AP‐1 in intact cells: AP‐1 as secondary antioxidant‐responsive factor by Meyer, M., Schreck, R., Baeuerle, P.A.

    Published in The EMBO journal (01-05-1993)
    “…We show that AP‐1 is an antioxidant‐responsive transcription factor. DNA binding and transactivation by AP‐1 were induced in HeLa cells upon treatment with the…”
    Get full text
    Journal Article
  2. 2

    Phosphorylation of human I kappa B‐alpha on serines 32 and 36 controls I kappa B‐alpha proteolysis and NF‐kappa B activation in response to diverse stimuli by Traenckner, E.B., Pahl, H.L., Henkel, T., Schmidt, K.N., Wilk, S., Baeuerle, P.A.

    Published in The EMBO journal (15-06-1995)
    “…Post‐translational activation of the higher eukaryotic transcription factor NF‐kappa B requires both phosphorylation and proteolytic degradation of the…”
    Get full text
    Journal Article
  3. 3

    A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF‐kappa B by Pahl, H.L., Baeuerle, P.A.

    Published in The EMBO journal (01-06-1995)
    “…The inducible, higher eukaryotic transcription factor NF‐kappa B is activated by a variety of external stimuli including inflammatory cytokines, viral and…”
    Get full text
    Journal Article
  4. 4

    Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1 by Schreck, R., Rieber, P., Baeuerle, P.A.

    Published in The EMBO journal (01-08-1991)
    “…Hydrogen peroxide and oxygen radicals are agents commonly produced during inflammatory processes. In this study, we show that micromolar concentrations of H2O2…”
    Get full text
    Journal Article
  5. 5

    The p65 subunit is responsible for the strong transcription activating potential of NF‐kappa B by Schmitz, M.L., Baeuerle, P.A.

    Published in The EMBO journal (01-12-1991)
    “…The nuclear form of the NF‐kappa B transcription factor binds to DNA as a heterodimer of a 50 kDa (p50) and 65 kDa (p65) polypeptide. The two polypeptides are…”
    Get full text
    Journal Article
  6. 6

    Nuclear uptake control of NF‐kappa B by MAD‐3, an I kappa B protein present in the nucleus by Zabel, U., Henkel, T., Silva, M.S., Baeuerle, P.A.

    Published in The EMBO journal (01-01-1993)
    “…I kappa B proteins specifically inhibit the DNA binding of NF‐kappa B/Rel transcription factors. An additional role as inhibitors of nuclear uptake was…”
    Get full text
    Journal Article
  7. 7

    NF‐kappa B contacts DNA by a heterodimer of the p50 and p65 subunit by Urban, M.B., Schreck, R., Baeuerle, P.A.

    Published in The EMBO journal (01-07-1991)
    “…We recently reported that the apparently non‐DNA‐binding 65 kd subunit (p65) of the NF‐kappa B transcription factor can modulate the DNA‐binding specificity of…”
    Get full text
    Journal Article
  8. 8

    A novel complex between the p65 subunit of NF‐kappa B and c‐Rel binds to a DNA element involved in the phorbol ester induction of the human urokinase gene by Hansen, S.K., Nerlov, C., Zabel, U., Verde, P., Johnsen, M., Baeuerle, P.A., Blasi, F.

    Published in The EMBO journal (01-01-1992)
    “…The NF‐kappa B subunits, p50 and p65, have extensive sequence homology with the c‐rel proto‐oncogene and the Drosophila morphogen dorsal. It has recently been…”
    Get full text
    Journal Article
  9. 9

    T lymphocytes can be effectively recruited for ex vivo and in vivo lysis of AML blasts by a novel CD33/CD3-bispecific BiTE antibody construct by Aigner, M, Feulner, J, Schaffer, S, Kischel, R, Kufer, P, Schneider, K, Henn, A, Rattel, B, Friedrich, M, Baeuerle, P A, Mackensen, A, Krause, S W

    Published in Leukemia (01-05-2013)
    “…Patients with acute myelogenous leukemia (AML) are in high need of novel targeted therapies. Here we explored the ex vivo activity of AMG330, a novel…”
    Get full text
    Journal Article
  10. 10

    The primary structure of bovine chromogranin A: a representative of a class of acidic secretory proteins common to a variety of peptidergic cells by Benedum, U.M., Baeuerle, P.A., Konecki, D.S., Frank, R., Powell, J., Mallet, J., Huttner, W.B.

    Published in The EMBO journal (01-07-1986)
    “…We have determined the primary structure of bovine chromogranin A as a first step in the elucidation of the function of this widespread protein. After…”
    Get full text
    Journal Article
  11. 11

    BiTEs: bispecific antibody constructs with unique anti-tumor activity by Wolf, Evelyn, Hofmeister, Robert, Kufer, Peter, Schlereth, Bernd, Baeuerle, Patrick A.

    Published in Drug discovery today (15-09-2005)
    “…Many new cancer therapies under development are trying to elicit specific T-cell responses against tumor cells. BiTE, a new class of bispecific antibodies, is…”
    Get full text
    Journal Article
  12. 12

    A revival of bispecific antibodies by Kufer, Peter, Lutterbüse, Ralf, Baeuerle, Patrick A.

    Published in Trends in biotechnology (Regular ed.) (01-05-2004)
    “…Bispecific antibodies usually do not occur in nature but are constructed by recombinant DNA or cell-fusion technologies. Most are designed to recruit cytotoxic…”
    Get full text
    Journal Article
  13. 13

    Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer by Schmidt, M., Rüttinger, D., Sebastian, M., Hanusch, C.A., Marschner, N., Baeuerle, P.A., Wolf, A., Göppel, G., Oruzio, D., Schlimok, G., Steger, G.G., Wolf, C., Eiermann, W., Lang, A., Schuler, M.

    Published in Annals of oncology (01-09-2012)
    “…Targeted therapy options in HER2-negative breast cancer are limited. This open-label, multicenter phase IB dose-escalation trial was conducted to determine…”
    Get full text
    Journal Article
  14. 14

    A proteasome inhibitor prevents activation of NF‐kappa B and stabilizes a newly phosphorylated form of I kappa B‐alpha that is still bound to NF‐kappa B by Traenckner, E.B., Wilk, S., Baeuerle, P.A.

    Published in The EMBO journal (15-11-1994)
    “…Activation of the inducible transcription factor NF‐kappa B involves removal of the inhibitory subunit I kappa B‐alpha from a latent cytoplasmic complex. It…”
    Get full text
    Journal Article
  15. 15

    Hepatitis B virus transactivator MHBst: activation of NF‐kappa B, selective inhibition by antioxidants and integral membrane localization by Meyer, M., Caselmann, W.H., Schlüter, V., Schreck, R., Hofschneider, P.H., Baeuerle, P.A.

    Published in The EMBO journal (01-08-1992)
    “…C‐terminal truncation of the middle surface antigen from hepatitis B virus (MHBs) gives rise to a novel transactivating protein, called MHBst. In this study we…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Tyrosine Sulfation Is a trans-Golgi-Specific Protein Modification by Baeuerle, Patrick A., Huttner, Wieland B.

    Published in The Journal of cell biology (01-12-1987)
    “…The trans-Golgi has been recognized as having a key role in terminal glycosylation and sorting of proteins. Here we show that tyrosine sulfation, a frequent…”
    Get full text
    Journal Article